14-day Premium Trial Subscription Try For FreeTry Free

Kinnate Biopharma Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -22.22. In total, the insiders bought 9 508 542 and sold 7 832 534 KNTE shares in the last 100 trades.

Insider Power

(Last 100 transactions)
-22.22
Buy 9 508 542 Shares
Sell 7 832 534 Shares

Historical Insider Trades

Date Type Action Person Amount
Apr 03, 2024 Common Stock Sell Tananbaum James B. 520 711
Apr 03, 2024 Stock Option (right to buy) Sell Tananbaum James B. 40 501
Apr 03, 2024 Stock Option (right to buy) Sell Tananbaum James B. 20 250
Apr 03, 2024 Common Stock Sell Farzan Nima 2 186
Apr 03, 2024 Stock Option (right to buy) Sell Farzan Nima 1 281 642
Apr 03, 2024 Stock Option (right to buy) Sell Farzan Nima 437 413
Apr 03, 2024 Stock Option (right to buy) Sell Farzan Nima 275 000
Apr 03, 2024 Stock Option (right to buy) Sell Farzan Nima 400 000
Apr 03, 2024 Stock Option (right to buy) Sell Farzan Nima 750 000
Apr 03, 2024 Stock Option (right to buy) Sell Mitchell Dean J 121 503
Apr 03, 2024 Stock Option (right to buy) Sell Mitchell Dean J 20 250
Apr 03, 2024 Stock Option (right to buy) Sell Mitchell Dean J 20 250
Apr 03, 2024 Stock Option (right to buy) Sell Mitchell Dean J 25 000
Apr 03, 2024 Common Stock Sell Krishnamohan Neha 64 087
Apr 03, 2024 Stock Option (right to buy) Sell Krishnamohan Neha 270 000
Apr 03, 2024 Stock Option (right to buy) Sell Krishnamohan Neha 185 000
Apr 03, 2024 Stock Option (right to buy) Sell Krishnamohan Neha 215 000
Apr 03, 2024 Stock Option (right to buy) Sell Smaldone Alsup Laurie 60 751
Apr 03, 2024 Stock Option (right to buy) Sell Smaldone Alsup Laurie 20 250
Apr 03, 2024 Stock Option (right to buy) Sell Smaldone Alsup Laurie 20 250
Apr 03, 2024 Stock Option (right to buy) Sell Smaldone Alsup Laurie 25 000
Apr 03, 2024 Stock Option (right to buy) Sell Epperly Melissa B, 60 751
Apr 03, 2024 Stock Option (right to buy) Sell Epperly Melissa B, 20 250
Apr 03, 2024 Stock Option (right to buy) Sell Epperly Melissa B, 25 000
Apr 03, 2024 Stock Option (right to buy) Sell Epperly Melissa B, 20 250
Click to get the best stock tips daily for free!

About Kinnate Biopharma Inc.

Kinnate Biopharma. Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growt... KNTE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT